Abstract
Green tea is now known to be the most effective beverage for cancer prevention, and evidence of this was recently extended to clinical applications. This paper briefly reviews several topics with regard to the development of our study on cancer prevention with green tea, and proposes a strategy for two-stages of cancer prevention with green tea. The topics are : 1) introduction of our initial work on (-)-epigallocatechin gallate (EGCG), the main constituent of Japanese green tea; 2) cancer preventive effects of EGCG and green tea extract, the lyophilized form of green tea infusion; 3) bioavailability of 3H-EGCG in mice; 4) delay of cancer onset by drinking 10 Japanese-size cups of green tea per day; 5) a prototype study for developing green tea beverage supplemented with green tea tablets by 102 healthy volunteers; 6) cancer prevention before cancer onset for the general population and high risk groups; 7) cancer prevention for patients following cancer treatment; 8) an example of a clinical trial looking toward prevention of cancer recurrence in the liver; and 9) possible prevention of human lung cancer. Considering all the above, green tea is a multi-, non-toxic cancer preventive for humans: It is natures remedy.
Keywords: green tea, egcg, 10 japanese-size cups, general population, cancer patients
Current Cancer Therapy Reviews
Title: Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment
Volume: 1 Issue: 1
Author(s): Hirota Fujiki, Masami Suganuma, Satoru Matsuyama and Kohji Miyazaki
Affiliation:
Keywords: green tea, egcg, 10 japanese-size cups, general population, cancer patients
Abstract: Green tea is now known to be the most effective beverage for cancer prevention, and evidence of this was recently extended to clinical applications. This paper briefly reviews several topics with regard to the development of our study on cancer prevention with green tea, and proposes a strategy for two-stages of cancer prevention with green tea. The topics are : 1) introduction of our initial work on (-)-epigallocatechin gallate (EGCG), the main constituent of Japanese green tea; 2) cancer preventive effects of EGCG and green tea extract, the lyophilized form of green tea infusion; 3) bioavailability of 3H-EGCG in mice; 4) delay of cancer onset by drinking 10 Japanese-size cups of green tea per day; 5) a prototype study for developing green tea beverage supplemented with green tea tablets by 102 healthy volunteers; 6) cancer prevention before cancer onset for the general population and high risk groups; 7) cancer prevention for patients following cancer treatment; 8) an example of a clinical trial looking toward prevention of cancer recurrence in the liver; and 9) possible prevention of human lung cancer. Considering all the above, green tea is a multi-, non-toxic cancer preventive for humans: It is natures remedy.
Export Options
About this article
Cite this article as:
Fujiki Hirota, Suganuma Masami, Matsuyama Satoru and Miyazaki Kohji, Cancer Prevention with Green Tea Polyphenols for the General Population, and for Patients Following Cancer Treatment, Current Cancer Therapy Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573394052952474
DOI https://dx.doi.org/10.2174/1573394052952474 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry Synthesis and Biological Evaluation of Novel Osthol Derivatives as Potent Cytotoxic Agents
Medicinal Chemistry Polymeric Nanomaterials as Nanomembrane Entities for Biomolecule and Drug Delivery
Current Pharmaceutical Design Foamy Virus Vectors: An Awaited Alternative to Gammaretro- and Lentiviral Vectors
Current Gene Therapy Gemini Surfactant Based Carriers in Gene and Drug Delivery
Current Medicinal Chemistry Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway
Anti-Cancer Agents in Medicinal Chemistry Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Current Cancer Drug Targets Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway
Current Molecular Medicine Radionuclide Based Imaging of Prostate Cancer
Current Topics in Medicinal Chemistry Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Synthetic Peptides in the Diagnosis of HIV Infection
Current Protein & Peptide Science Artificial Intelligence Techniques for Colorectal Cancer Drug Metabolism: Ontologies and Complex Networks
Current Drug Metabolism CYP17 Inhibitors for Prostate Cancer Treatment – An Update
Current Medicinal Chemistry MiRNA-29: A microRNA Family with Tumor-Suppressing and Immune-Modulating Properties
Current Molecular Medicine Current Application of Quantum Dots (QD) in Cancer Therapy: A Review
Mini-Reviews in Medicinal Chemistry Global Gene Expression in Classification, Pathogenetic Understanding and Identification of Therapeutic Targets in Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology